论文部分内容阅读
1989年至1995年为16例肺恶性肿瘤病人施行了26次非典型性局限性肺切除。周围型肺癌5例。1例腺癌病人（T3N2M0）于术后1年6个月死亡。其余2例腺癌（T1N0M0，T2N0M0）病人，1例肺叶切除复发的腺癌病例和1例小细胞癌（T2N0M0）病人生存至今，已分别超过3年6个月，2，和1年。肺转移瘤11例，3例为单发转移，8例为双肺多发性转移瘤。11例病人进行20次非典型性局限性切除，其切除转移瘤143个，平均每例13个。4例于术手6年，1年，10个月和8个月死亡。余7例生存至今，已分别超过3年（3例），2年（3例），1年（1例）。非典型性局限性肺切除不同于经典的肺叶切除术，肺段切除和肺楔形切除术。本手术具有不少优点：肺组织损失少，操作简便，可以切除肺组织深部病变和多发性病变，从而避免肺叶切除或全肺切除而保存更多的肺组织。
From 1989 to 1995, 26 cases of lung cancer patients underwent 26 cases of atypical localized lung resection. Peripheral lung cancer in 5 cases. One patient with adenocarcinoma (T3N2M0) died 1 year and 6 months after surgery. The remaining 2 patients with adenocarcinoma (T1N0M0, T2N0M0), 1 patient with recurrent lobectomy, and 1 patient with small cell carcinoma (T2N0M0) survived more than 3 years, 6 months, 2, and 1 year respectively. There were 11 cases of lung metastases, 3 cases of solitary metastases, and 8 cases of multiple metastatic lung tumors. Eleven patients underwent 20 cases of atypical localized resection. 143 metastatic tumors were resected, with an average of 13 cases. Four patients died 6 years, 1 year, 10 months and 8 months after surgery. The remaining 7 cases have survived so far and have been more than 3 years (3 cases), 2 years (3 cases), and 1 year (1 case). Atypical localized lung resection is different from classic lobectomy, segmentectomy, and wedge resection. The surgery has many advantages: less loss of lung tissue, easy operation, can remove deep lesions and multiple lesions of the lung tissue, thereby avoiding lobectomy or pneumonectomy to save more lung tissue.